Cancer Research and Treatment

Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure

Xiaohui Hua, Ronghao Zou, Xiaoyue Bai, Yuyao Yang, Juan Lu, Chuanshu Huang

Systematic investigation of biomarker-like role of ARHGDIB in breast cancer

Xiaonan Wang, Xiaomin Bi, Xing Huang, Bijun Wang, Qianying Guo, Zhengsheng Wu

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

Stefan Steurer, Benjamin Hager, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Sarah Minner, Till S. Clauditz, Claudia Hube-Magg, Andreas M. Luebke, Ronald Simon, Jakob R. Izbicki, Eike Burandt, Guido Sauter, Christoph Fraune, Sören Weid

Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation

Ming-Chun Lai, Qian-Qian Zhu, Kwabena-Gyabaah Owusu-Ansah, Yang-Bo Zhu, Zhe Yang, Hai-Yang Xie, Lin Zhou, Li-Ming Wu, Shu-Sen Zheng

RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway

Huiyan Niu, Baogang Wu, Yang Peng, Hongfang Jiang, Yi Zhang, Jiahe Wang, Yifei Zhang, Ping He

Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors

Jonathan Hensel, Jason E. Duex, Charles Owens, Garrett M. Dancik, Michael G. Edwards, Henry F. Frierson, Dan Theodorescu

Molecular Cancer Research.2015; 13(9): 1306. CrossRef

Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9

Marcos A. Muñiz Lino, Yadira Palacios-Rodríguez, Sergio Rodríguez-Cuevas, Verónica Bautista-Piña, Laurence A. Marchat, Erika Ruíz-García, Horacio Astudillo-de la Vega, Ana E. González-Santiago, Ali Flores-Pérez, José Díaz-Chávez, Ángeles Carlos-Reyes, Eli

Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway

Weiming Duan, Yaxiang Xu, YuJin Dong, Lili Cao, Jian Tong, Xinwen Zhou

Journal of Radiation Research.2013; 54(4): 611. CrossRef

Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3

QINGHUA ZHAO, HAIFENG WANG, MINGYING YANG, DELIN YANG, YIGANG ZUO, JIANSONG WANG

Experimental and Therapeutic Medicine.2013; 5(3): 942. CrossRef

RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration

Neveen Said, Marta Sanchez-Carbayo, Steven C. Smith, Dan Theodorescu

Journal of Clinical Investigation.2012; 122(4): 1503. CrossRef

Overexpression of RhoGDI2 Correlates with Tumor Progression and Poor Prognosis in Colorectal Carcinoma

Xianzheng Li, Jianmei Wang, Xiaojing Zhang, Yuanfeng Zeng, Li Liang, Yanqing Ding

Annals of Surgical Oncology.2012; 19(1): 145. CrossRef

Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma

Haifeng Wang, Jiansong Wang, Yigang Zuo, Mingxia Ding, Ruping Yan, Delin Yang, Changxin Ke

The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder

T Qayyum, G Fyffe, M Duncan, P A McArdle, M Hilmy, C Orange, G Halbert, M Seywright, P G Horgan, M A Underwood, J Edwards

British Journal of Cancer.2012; 106(6): 1187. CrossRef

Cancer and Metastasis Reviews.2012; 31(3-4): 519. CrossRef

Breast cancer proteomics reveals a positive correlation between glyoxalase 1 expression and high tumor grade

MIGUEL A. FONSECA-SÁNCHEZ, SERGIO RODRÍGUEZ CUEVAS, GUILLERMO MENDOZA-HERNÁNDEZ, VERONICA BAUTISTA-PIÑA, ELENA ARECHAGA OCAMPO, ALFREDO HIDALGO MIRANDA, VALERIA QUINTANAR JURADO, LAURENCE A. MARCHAT, ELIZBETH ÁLVAREZ-SÁNCHEZ, CARLOS PÉREZ PLASENCIA, CÉSAR

International Journal of Oncology.2012; 41(2): 670. CrossRef

Reactive Center Loop Moiety Is Essential for the Maspin Activity on Cellular Invasion and Ubiquitin‐Proteasome Level

Chakkrit Khanaree, Kongthawat Chairatvit, Sittiruk Roytrakul, Ariyaphong Wongnoppavich

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.2012; 20(9): 427. CrossRef

NFIB is a potential target for estrogen receptor‐negative breast cancers

Hyeong-Gon Moon, Ki-Tae Hwang, Jeong-Ah Kim, Hee Sung Kim, Min-Joo Lee, Eun-Mi Jung, Eunyoung Ko, Wonshik Han, Dong-Young Noh